Michaela Fleming

A new analysis reports that 1 in 4 infants with bronchiolitis was given an antibiotic despite the fact that 70% of patients did not meet prescribing recommendations set by the American Academy of Pediatrics.

A new test can detect Plasmodium falciparum gametocyte carriers in saliva samples, providing a point-of-need rapid diagnostic test for malaria.

FDA has granted Fast Track designation for ACX-362E, an investigational new treatment for C diff that is being developed by Acurx Pharmaceuticals, LLC.

To explore the long-term outcomes of treatment for recurrent C diff, NIAID has launched a new trial that will follow patients for 4 years to assess the safety of fecal microbiota transplants.

A large cohort study in South Korea found that human metapneumovirus associated pneumonia cases were strongly associated with older age, current smoking, and underlying disease.

The FDA has approved the launch of the first in-human clinical trial evaluating the efficacy of a new synthetic DNA-encoded monoclonal antibody (DMAb) therapy to prevent Zika virus infection.

Between 2016 and 2018, Typhi infections susceptible only to azithromycin and carbapenems were identified in 5372 individuals in Pakistan and 5 children in the US following travel to Pakistan.

At Day 28, 100% seroconversion rate was achieved in a pooled analysis of all participants who received a single vaccination of VLA1553.

Investigators have identified and characterized Mengla virus, a filovirus that is genetically distinct from Ebola and Marburg viruses.

Despite the increase of live poultry-related Salmonella outbreaks, environmental sampling at hatcheries is not routinely conducted leaving the outbreak source unknown.

As health officials in Nebraska monitor an American potentially exposed to Ebola, outbreak response activities have been impeded in the DRC following the cutting of internet connections by the government.

Yemen is currently experiencing the largest recorded cholera outbreak in history, and investigators have determined that migration from Eastern Africa brought the outbreak strain into the nation.

A new study reports that antibiotic resistance appears to be linked with widespread occasional use than by repeated use among a small number of individuals in a population.

In a prospective cohort analysis of over 240,000 adults, individuals with cancer had about a 40% higher risk of developing herpes zoster.

The CDC and FDA announced today that a positive sample of the romaine lettuce outbreak strain was found in the sediment of an irrigation system at Adam Bros. Farms in Santa Barbara, California.

A study found that the climate of the eastern area of the United States is similar to the native habitat of the Asian longhorned tick in Asia and Australia, which suggests the tick will become more common in the US.

The FDA has approved a 65 mg capsule of SUBA-itraconazole for the treatment of 3 systematic fungal infections in adult patients.

The Center for Devices and Radiological Health of the US FDA has issued clearance for the Thermo Scientific QMS Plazomicin Immunoassay.

On December 1, 2018, international health organizations reflected on the advancements of the HIV/AIDS research field and acknowledged the challenges that still remain such as treating comorbidities and confronting stigma.

A lack of funding is currently hindering response where it’s needed most; the supply of clean water and sanitation.

TY014 is the first candidate drug to be evaluated in clinical trials for the treatment of yellow fever.

Pharmacokinetic analyses provide evidence to support once-weekly dosing of rezafungin to prevent Aspergillus fumigatus in bone marrow transplant recipients.

A new study found that individuals who had low microbiota diversity prior to a bone marrow transplant were more likely to be at a higher risk for post-transplant complications.

Little is known about the ecology and biology of the dangerous tick that the CDC has labeled an emerging disease threat to both humans and animals.

Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.

The FDA has announced that tahini imported from Israel is the likely source of a multistate outbreak of Salmonella Concord.

A new trial evaluating the efficacy of investigational therapeutics mAb114, remdesivir, and ZMapp has launched in the Democratic Republic of the Congo.

Secondary analyses indicate that bezlotoxumab is more effective in reducing C diff recurrence in patients with pre-specified risk factors.

Health officials are investigating an outbreak of Listeria monocytogenes in 4 states with a suspected link to ready-to-eat pork products.

The new response program will focus on scaling up prevention and treatment efforts for malaria and increasing financial investments to better protect vulnerable populations.